bayer.co.at Listed by lockbit2 Ransomware Group: Ransomware Claim — What’s Alleged & What To Do
The bayer.co.at Listed by lockbit2 Ransomware Group (reported February 7, 2022) is an unverified claim; the data involved is undisclosed belonging to roughly unknown people. If you have an account with them, your information may now be circulating on the open web and with data brokers. Here’s exactly what happened, how to check if you were affected, and what to do next.
On February 7, 2022, the domain bayer.co.at appeared on a leak site operated by the ransomware group lockbit2. The listing indicated that internal files had been taken during a ransomware operation, though the number of individuals affected and the precise contents of the material remain undisclosed in public reporting.
The incident is significant because bayer.co.at operates in the pharmaceutical and life-sciences sector, where internal records frequently include research, regulatory, and commercial information that is not intended for public release.
What happened
Public records show only that bayer.co.at was listed on the lockbit2 leak site on February 7, 2022. The group stated that it had exfiltrated internal files. No confirmed count of affected individuals, no list of specific file types, and no verified timeline of the intrusion have been released by the organization or by investigators.
Details such as the initial access method, the duration of access, or whether encryption was also deployed are not publicly documented. The sole confirmed element is the appearance of the domain on the group’s leak site and the accompanying claim of data theft.
Who is lockbit2?
Lockbit2 is a ransomware operation that has been active since at least 2019. It is known for using a ransomware-as-a-service model in which affiliates deploy the malware and the core group supplies the encryption tools and leak infrastructure. The group commonly employs double-extortion tactics: data is encrypted on victim systems and a copy is also removed, after which the operators threaten to publish the stolen material if a ransom is not paid.
Lockbit2 maintains a public leak site where it lists organizations it claims to have compromised. Listings on this site constitute an assertion by the group; independent confirmation of the claims is not automatic and must be assessed separately for each case.
About bayer.co.at
Bayer.co.at is the Austrian web presence of Bayer AG, a multinational company whose primary activities include the development and distribution of pharmaceuticals, consumer health products, and crop-science solutions. Organizations of this type routinely maintain internal systems that store research data, clinical-trial records, regulatory submissions, supply-chain information, and employee or partner correspondence.
Because such records can contain proprietary scientific information and personal data relating to patients, trial participants, or staff, any unauthorized access carries implications for both commercial confidentiality and individual privacy.
What was likely exposed
The only data category named in connection with the listing is “internal files exfiltrated in ransomware attack.” No further breakdown of file contents, record counts, or data categories has been published.
Entities in the pharmaceutical sector typically hold research documentation, regulatory filings, employee records, and commercial agreements. Whether any of these specific categories were among the files referenced in the lockbit2 listing has not been confirmed.
Why it matters
Internal files from a pharmaceutical organization can include information that affects competitive positioning, regulatory compliance, and the privacy of individuals whose data appears in research or operational records. Even without Reported Details on the exact material, the existence of an exfiltration claim requires affected organizations to evaluate potential downstream risks to research integrity and to individuals whose information may have been copied.
For the organization, the incident adds to the workload of incident response, regulatory notification assessment, and any subsequent remediation steps required under applicable data-protection rules.
If your data was in this claimed breach
Individuals who have interacted with Bayer in Austria or who hold accounts associated with bayer.co.at should monitor official communications from the company for any direct notification. Practical steps include reviewing recent account activity, enabling or strengthening multi-factor authentication on any linked services, and remaining alert for unsolicited messages that reference personal details.
Readers may also run a free exposure scan of their email address against known breach data sets to determine whether their information appears in publicly documented incidents.
AICompiled with AI assistance from public sources and published under our editorial standards.
How this breach connects
More recent breaches
tb-kawashima.co... Listed by lockbit2 Ransomware Groupkeisei- Listed by lockbit2 Ransomware Grouphttps://www.tb-... Listed by lockbit2 Ransomware Groupenclosuresoluti Listed by lockbit2 Ransomware GroupLatest breaches
Read GalaxyWarden’s full analysis of the bayer.co.at Listed by lockbit2 Ransomware Group →
Publicly posted by lockbit — unverified claim, pending independent verification
Breach listings — particularly those originating from ransomware or leak sites — are third-party claims that may be unverified, incomplete, or inaccurate. A listing does not by itself confirm that a breach occurred or that any specific data was exposed. Severity is an automated assessment, not a definitive rating. Verification status is shown where available.
Attributions to threat groups and methods reflect public reporting and, in some cases, unverified claims made by the groups themselves; they may be incomplete or later revised. Recent Breaches and GalaxyWarden are independent and are not affiliated with, and do not endorse, any company or group named on this page. This information is aggregated from public sources for awareness only and is not legal, security, or investment advice.